OM1
Boston, US · 3 known investors
OM1 develops AI-powered analytics and data infrastructure for healthcare organizations to measure patient outcomes, predict health trajectories, and accelerate medical research using real-world clinical data. The platform serves healthcare systems, pharmaceutical companies, and research organizations seeking to close evidence gaps and improve clinical decision-making.
Founders & leadership
RG
Richard Gliklich, MDFounder
Investors · 3
In the news
- OM1 - 2026 Company Profile, Team, Funding & Competitors - Tracxntracxn.com · 2021
- OM1 - 2026 Funding Rounds & List of Investors - Tracxntracxn.com · 2021
- OM1 Raises $85M in Funding - FinSMEsfinsmes.com · 2021
- OM1's real-world evidence analytics banks $50M Series C | MobiHealthNewsmobihealthnews.com · 2019
- Real-World Outcomes & Technology Company OM1 Closes $50 Million Series C Financing To Make Healthcare More Measured, Precise, And Pre-Emptiveprnewswire.com · 2019
- OM1 Raises $15M to Expand Healthcare Outcome Analytics Platform - HIT Consultanthitconsultant.net · 2017